Skip to Main Content

Author Details

Jianhua Wang
Anhui University of Science & Technology
2005
51
31
PMIDPaper TitleJournal TitlePublished Year
36111403Retraction: CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway.Cancer Res2022
35738192Withdrawal: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.J Biol Chem2022
35853880Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression.Cell Death Dis2022
36111404Retraction: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression.Cancer Res2022
33419984Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway.Oncogenesis2021
33723003Retraction: A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer.Cancer Res2021
34430408Comprehensive analysis of alternative splicing profiling reveals novel events associated with prognosis and the infiltration of immune cells in prostate cancer.Transl Androl Urol2021
33454172Retraction notice to <"Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis"> <[Cellular Signaling 17/12 (2005) 1578-1592]>.Cell Signal2021
33420488Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression.Nat Cell Biol2021
31597953Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway.Oncogene2020
31919406MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39.Br J Cancer2020
32801300LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression.Cell Death Dis2020
30312658Loss of hypermethylated in cancer 1 (HIC1) promotes lung cancer progression.Cell Signal2019
31762813Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway.J Cancer2019
30925930Microvesicles and chemokines in tumor microenvironment: mediators of intercellular communications in tumor progression.Mol Cancer2019
29065111Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library.Br J Cancer2018
30204129HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk.J Clin Invest2018
29175422Targeting CXCR7 improves the efficacy of breast cancer patients with tamoxifen therapy.Biochem Pharmacol2018
28466555HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.J Pathol2017
26818357The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis.Carcinogenesis2016
27874079Crosstalk among proteome, acetylome and succinylome in colon cancer HCT116 cell treated with sodium dichloroacetate.Sci Rep2016
27107418Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.Oncotarget2016
25687182USP2 promotes cell migration and invasion in triple negative breast cancer cell lines.Tumour Biol2015
25909173CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.Oncotarget2015
25880371Bmi-1 expression modulates non-small cell lung cancer progression.Cancer Biol Ther2015
24295734HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2.Cancer Res2014
24909173IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer.Oncogene2014
24514954PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients.Cancer Immunol Immunother2014
23114846Stromal cells in tumor microenvironment and breast cancer.Cancer Metastasis Rev2013
23814023Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer.Mol Cancer Res2013
23957561Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer.BMC Cancer2013
23653207Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis.Nat Commun2013
23340301HIC1 modulates prostate cancer progression by epigenetic modification.Clin Cancer Res2013
22525723Role of chemokine receptor CXCR7 in bladder cancer progression.Biochem Pharmacol2012
22528874Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression.Cancer Microenviron2012
20068185Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.Cancer Res2010
20839032CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.Cancer Metastasis Rev2010
20523730Erythropoietin couples hematopoiesis with bone formation.PLoS One2010
19825988Expression of PGK1 by prostate cancer cells induces bone formation.Mol Cancer Res2009
18057003The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.J Biol Chem2008
19074906CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.Cancer Res2008
18636554Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer.J Cell Biochem2008
18344492CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.Mol Cancer Res2008
17210694A glycolytic mechanism regulating an angiogenic switch in prostate cancer.Cancer Res2007
17360942Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation.Blood2007
17034033Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.Prostate2007
16337237Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.Bone2006
17165132The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.Cancer Metastasis Rev2006
15647826Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.J Bone Miner Res2005
16005185Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis.Cell Signal2005
  • 1 - 50 of 51

Recommended Authors

Yunyun Zhou
Children's Hospital of Philadelphia
Career Start Year 2015
Number of shared co-authors 1
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 0
Zitong Zhao
School of Pharmacy, Wannan Medical College
Career Start Year 2012
Number of shared co-authors 0
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Estelle Li
University of British Columbia
Career Start Year 2012
Number of shared co-authors 7
Doreen Heckmann
University Children's Hospital
Career Start Year 2011
Number of shared co-authors 1
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 9
Yusuke Goto
Chiba University Graduate School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
Helen He Zhu
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Ruby Yun-Ju Huang
National Taiwan University College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 3
Xiaoyong Huang
Medical College, Yan'an University
Career Start Year 2007
Number of shared co-authors 3
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 5
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 7
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 1
Hae-Yun Jung
College of Life Science, CHA University
Career Start Year 2003
Number of shared co-authors 0
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 7
Limei Hu
Aier Eye Hospital of Wuhan University
Career Start Year 2001
Number of shared co-authors 0
Wei Zhang
Children's Hospital, Zhejiang University School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Youn-Jae Kim
Research Institute, National Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 10
Alana L Welm
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Career Start Year 1996
Number of shared co-authors 9
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 6
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 5

Collaborators

Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 12
Xiaojie Bian
Fudan University Shanghai Cancer Center
Co-authored papers 5
Cun-Yu Wang
University of California, Los Angeles (university of california los angeles)
Co-authored papers 4
Paul H Krebsbach
Co-authored papers 4
Shancheng Ren
Shanghai Changzheng Hospital
Co-authored papers 3
Yu-Tian Xiao
Shanghai Changhai Hospital, Naval Medical University
Co-authored papers 3
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 2
Chao Wang
Novel Bioinformatics Co.
Co-authored papers 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Yasheng Zhu
Changhai Hospital, Naval Military Medical University
Co-authored papers 1
Song Wu
The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group)
Co-authored papers 1
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 1
Na Zhang
Obstetrics and Gynecology Hospital of Fudan University
Co-authored papers 1
Fubo Wang
Center for Genomic and Personalized Medicine, Guangxi Medical University
Co-authored papers 1
Fei Liu
Shanghai Changhai Hospital
Co-authored papers 1
Bo Zhang
Novel Bioinformatics Co.
Co-authored papers 1
Weidong Chen
Novel Bioinformatics Co.
Co-authored papers 1
Dai Chen
University of Washington
Co-authored papers 1
Zhengfang Yi
The Institute of Biomedical Sciences, East China Normal University
Co-authored papers 1
Helen Loo Yau
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Qinghua Guo
Novel Bioinformatics Co.
Co-authored papers 1
Zhou Jiang
China University of Geosciences
Co-authored papers 1
Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 1
Daniel D De Carvalho
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 1
Yin Liu
Fudan University Shanghai Cancer Center
Co-authored papers 1
Keqin Dong
Shanghai Changhai Hospital
Co-authored papers 1
Jiayi Wu
Co-authored papers 1
Dolores Di Vizio
Cedars-Sinai Medical Center
Co-authored papers 1
Release 1.2